Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
November-2017 Volume 14 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
November-2017 Volume 14 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Tectorigenin attenuates the MPP+‑induced SH‑SY5Y cell damage, indicating a potential beneficial role in Parkinson's disease by oxidative stress inhibition

  • Authors:
    • Ping Gong
    • Fang Deng
    • Wei Zhang
    • Jin Ji
    • Jia Liu
    • Yinan Sun
    • Jiayu Hu
  • View Affiliations / Copyright

    Affiliations: Department of Geriatrics, Third Hospital of Peking University, Beijing 100191, P.R. China, Department of Neurology, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China, Department of Neurological Disease Center, Beijing Friendship Hospital Affiliated to The Capital University of Medical Sciences, Beijing 100050, P.R. China
  • Pages: 4431-4437
    |
    Published online on: August 28, 2017
       https://doi.org/10.3892/etm.2017.5049
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Tectorigenin is a plant isoflavonoid primarily derived from the flowers of Pueraria thomsonii Benth. Although various biological properties of tectorigenin have been reported, such as its antioxidant activity, the effects of tectorigenin on the cellular models of Parkinson's disease have not yet been elucidated. The aims of the current study were to investigate whether tectorigenin prevents neurotoxicity induced by MPP+ (also known as 1‑methyl‑4‑phenylpyridinium) in SH‑SY5Y cells and to elucidate the underlying protective mechanism. Cell viability and lactate dehydrogenase release were measured. The morphological changes of apoptotic cells were observed by Hoechst 33258 staining. Caspase‑3, superoxide dismutase, catalase and glutathione peroxidase activity was measured using commercially available ELISA kits. The expression of cytochrome c, Bax, Bcl‑2 and NADPH oxidase were detected by western blot analysis. The results indicated that treatment with MPP+ causes a significant decrease in the viability of cells and an increase in apoptosis, as evidenced by the upregulation of apoptotic cells, caspase‑3 activity and cytochrome c expression. By contrast, these effects were all reversed by pretreatment with tectorigenin in SH‑SY5Y cells. Tectorigenin also inhibited the MPP+‑induced changes of Bax and Bcl‑2 levels. In addition, pretreatment with tectorigenin mitigated the MPP+‑caused increases in the levels of reactive oxygen species and NADPH oxidase protein in SH‑SY5Y cells. Simultaneously, tectorigenin abolished the downregulation of antioxidant enzymes, including superoxide dismutase, catalase and glutathione peroxidase, that was induced by MPP+. In conclusion, the present study data indicate that the neuroprotective effect of tectorigenin against MPP+‑induced cytotoxicity and apoptosis may be involved in attenuating oxidative stress and enhancing antioxidant defense.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Lo Bianco C, Schneider BL, Bauer M, Sajadi A, Brice A, Iwatsubo T and Aebischer P: Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson's disease. Proc Natl Acad Sci USA. 101:17510–17515. 2004. View Article : Google Scholar : PubMed/NCBI

2 

Jellinger KA: The pathology of Parkinson's disease. Adv Neurol. 86:55–72. 2001.PubMed/NCBI

3 

Bales A, Peterson MJ, Ojha S, Upadhaya K, Adhikari B and Barrett B: Associations between betel nut (Areca catechu) and symptoms of schizophrenia among patients in Nepal: A longitudinal study. Psychiatry Res. 169:203–211. 2009. View Article : Google Scholar : PubMed/NCBI

4 

Beal MF: Mitochondria, oxidative damage, and inflammation in Parkinson's disease. Ann N Y Acad Sci. 991:120–131. 2003. View Article : Google Scholar : PubMed/NCBI

5 

Moon HE and Paek SH: Mitochondrial dysfunction in Parkinson's disease. Exp Neurobiol. 24:103–116. 2015. View Article : Google Scholar : PubMed/NCBI

6 

Blesa J, Trigo-Damas I, Quiroga-Varela A and Jackson-Lewis VR: Oxidative stress and Parkinson's disease. Front Neuroanat. 9:912015. View Article : Google Scholar : PubMed/NCBI

7 

Kim GH, Kim JE, Rhie SJ and Yoon S: The role of oxidative stress in neurodegenerative diseases. Exp neurobiol. 24:325–340. 2015. View Article : Google Scholar : PubMed/NCBI

8 

Turski L, Bressler K, Rettig KJ, Loschmann PA and Wachtel H: Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists. Nature. 349:414–418. 1991. View Article : Google Scholar : PubMed/NCBI

9 

Singer TP and Ramsay RR: Mechanism of the neurotoxicity of MPTP. An update. FEBS Lett. 274:1–8. 1990. View Article : Google Scholar : PubMed/NCBI

10 

Han YO, Han MJ, Park SH and Kim DH: Protective effects of kakkalide from Flos puerariae on ethanol-induced lethality and hepatic injury are dependent on its biotransformation by human intestinal microflora. J pharmacol Sci. 93:331–336. 2003. View Article : Google Scholar : PubMed/NCBI

11 

Gutierrez-Zepeda A, Santell R, Wu Z, Brown M, Wu Y, Khan I, Link CD, Zhao B and Luo Y: Soy isoflavone glycitein protects against beta amyloid-induced toxicity and oxidative stress in transgenic Caenorhabditis elegans. BMC Neurosci. 6:542005. View Article : Google Scholar : PubMed/NCBI

12 

Yuan D, Xie YY, Bai X, Wu X, Yang JY and Wu CF: Inhibitory activity of isoflavones of Pueraria flowers on nitric oxide production from lipopolysaccharide-activated primary rat microglia. J Asian Nat Prod Res. 11:471–481. 2009. View Article : Google Scholar : PubMed/NCBI

13 

Han T, Cheng G, Liu Y, Yang H, Hu YT and Huang W: in vitro evaluation of tectoridin, tectorigenin and tectorigenin sodium sulfonate on antioxidant properties. Food Chem Toxicol. 50:409–414. 2012. View Article : Google Scholar : PubMed/NCBI

14 

Park EK, Shin YW, Lee HU, Lee CS and Kim DH: Passive cutaneous anaphylaxis-inhibitory action of tectorigenin, a metabolite of tectoridin by intestinal microflora. Biol Pharm Bull. 27:1099–1102. 2004. View Article : Google Scholar : PubMed/NCBI

15 

Lee KT, Sohn IC, Kim DH, Choi JW, Kwon SH and Park HJ: Hypoglycemic and hypolipidemic effects of tectorigenin and kaikasaponin III in the streptozotocin-lnduced diabetic rat and their antioxidant activity in vitro. Arch Pharm Res. 23:461–466. 2000. View Article : Google Scholar : PubMed/NCBI

16 

Kang KA, Lee KH, Chae S, Zhang R, Jung MS, Kim SY, Kim HS, Kim DH and Hyun JW: Cytoprotective effect of tectorigenin, a metabolite formed by transformation of tectoridin by intestinal microflora, on oxidative stress induced by hydrogen peroxide. Eur J pharmacol. 519:16–23. 2005. View Article : Google Scholar : PubMed/NCBI

17 

Park JS, Jung JS, Jeong YH, Hyun JW, Le TK, Kim DH, Choi EC and Kim HS: Antioxidant mechanism of isoflavone metabolites in hydrogen peroxide-stimulated rat primary astrocytes: Critical role of hemeoxygenase-1 and NQO1 expression. J neurochem. 119:909–919. 2011. View Article : Google Scholar : PubMed/NCBI

18 

Racher AJ, Looby D and Griffiths JB: Use of lactate dehydrogenase release to assess changes in culture viability. Cytotechnology. 3:301–307. 1990. View Article : Google Scholar : PubMed/NCBI

19 

Katunina EA, Titova NV, Malykhina EA, Gasanov MG, Makarova AA, Voronina TA, Nerobkova LN, Valdman EA and Avakyan GN: Oxidative stress and Parkinson's disease: Mechanisms and perspectives of treatment. Zh Nevrol Psikhiatr Im S S Korsakova. 115:141–145. 2015. View Article : Google Scholar : PubMed/NCBI

20 

Sorce S and Krause KH: NOX enzymes in the central nervous system: From signaling to disease. Antioxid redox signal. 11:2481–2504. 2009. View Article : Google Scholar : PubMed/NCBI

21 

Markey SP, Johannessen JN, Chiueh CC, Burns RS and Herkenham MA: Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism. Nature. 311:464–467. 1984. View Article : Google Scholar : PubMed/NCBI

22 

Khwanraj K, Phruksaniyom C, Madlah S and Dharmasaroja P: Differential expression of tyrosine hydroxylase protein and apoptosis-related genes in differentiated and undifferentiated SH-SY5Y neuroblastoma cells treated with MPP+. Neurol Res Int. 2015:7347032015. View Article : Google Scholar : PubMed/NCBI

23 

Subramaniam SR and Chesselet MF: Mitochondrial dysfunction and oxidative stress in Parkinson's disease. Prog Neurobiol. 106–107:17–32. 2013. View Article : Google Scholar

24 

Houghton PJ and Howes MJ: Natural products and derivatives affecting neurotransmission relevant to Alzheimer's and Parkinson's disease. Neurosignals. 14:6–22. 2005. View Article : Google Scholar : PubMed/NCBI

25 

Mythri RB, Harish G and Bharath MM: Therapeutic potential of natural products in Parkinson's disease. Recent Pat Endocr Metab Immune Drug Discov. 6:181–200. 2012. View Article : Google Scholar : PubMed/NCBI

26 

Fu W, Zhuang W, Zhou S and Wang X: Plant-derived neuroprotective agents in Parkinson's disease. Am J Transl Res. 7:1189–1202. 2015.PubMed/NCBI

27 

Jang MH, Shin MC, Kim YJ, Chung JH, Yim SV, Kim EH, Kim Y and Kim CJ: Protective effects of Puerariae flos against ethanol-induced apoptosis on human neuroblastoma cell line SK-N-MC. Jap J Pharmacol. 87:338–342. 2001. View Article : Google Scholar : PubMed/NCBI

28 

Stadtman ER: Role of oxidant species in aging. Curr Med Chem. 11:1105–1112. 2004. View Article : Google Scholar : PubMed/NCBI

29 

Lohr JB and Browning JA: Free radical involvement in neuropsychiatric illnesses. Psychopharmacol Bull. 31:159–165. 1995.PubMed/NCBI

30 

Di Monte D, Sandy MS, Ekström G and Smith MT: Comparative studies on the mechanisms of paraquat and 1-methyl-4-phenylpyridine (MPP+) cytotoxicity. Biochem Biophys Res Commun. 137:303–309. 1986. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Gong P, Deng F, Zhang W, Ji J, Liu J, Sun Y and Hu J: Tectorigenin attenuates the MPP+‑induced SH‑SY5Y cell damage, indicating a potential beneficial role in Parkinson's disease by oxidative stress inhibition. Exp Ther Med 14: 4431-4437, 2017.
APA
Gong, P., Deng, F., Zhang, W., Ji, J., Liu, J., Sun, Y., & Hu, J. (2017). Tectorigenin attenuates the MPP+‑induced SH‑SY5Y cell damage, indicating a potential beneficial role in Parkinson's disease by oxidative stress inhibition. Experimental and Therapeutic Medicine, 14, 4431-4437. https://doi.org/10.3892/etm.2017.5049
MLA
Gong, P., Deng, F., Zhang, W., Ji, J., Liu, J., Sun, Y., Hu, J."Tectorigenin attenuates the MPP+‑induced SH‑SY5Y cell damage, indicating a potential beneficial role in Parkinson's disease by oxidative stress inhibition". Experimental and Therapeutic Medicine 14.5 (2017): 4431-4437.
Chicago
Gong, P., Deng, F., Zhang, W., Ji, J., Liu, J., Sun, Y., Hu, J."Tectorigenin attenuates the MPP+‑induced SH‑SY5Y cell damage, indicating a potential beneficial role in Parkinson's disease by oxidative stress inhibition". Experimental and Therapeutic Medicine 14, no. 5 (2017): 4431-4437. https://doi.org/10.3892/etm.2017.5049
Copy and paste a formatted citation
x
Spandidos Publications style
Gong P, Deng F, Zhang W, Ji J, Liu J, Sun Y and Hu J: Tectorigenin attenuates the MPP+‑induced SH‑SY5Y cell damage, indicating a potential beneficial role in Parkinson's disease by oxidative stress inhibition. Exp Ther Med 14: 4431-4437, 2017.
APA
Gong, P., Deng, F., Zhang, W., Ji, J., Liu, J., Sun, Y., & Hu, J. (2017). Tectorigenin attenuates the MPP+‑induced SH‑SY5Y cell damage, indicating a potential beneficial role in Parkinson's disease by oxidative stress inhibition. Experimental and Therapeutic Medicine, 14, 4431-4437. https://doi.org/10.3892/etm.2017.5049
MLA
Gong, P., Deng, F., Zhang, W., Ji, J., Liu, J., Sun, Y., Hu, J."Tectorigenin attenuates the MPP+‑induced SH‑SY5Y cell damage, indicating a potential beneficial role in Parkinson's disease by oxidative stress inhibition". Experimental and Therapeutic Medicine 14.5 (2017): 4431-4437.
Chicago
Gong, P., Deng, F., Zhang, W., Ji, J., Liu, J., Sun, Y., Hu, J."Tectorigenin attenuates the MPP+‑induced SH‑SY5Y cell damage, indicating a potential beneficial role in Parkinson's disease by oxidative stress inhibition". Experimental and Therapeutic Medicine 14, no. 5 (2017): 4431-4437. https://doi.org/10.3892/etm.2017.5049
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team